BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 19637973)

  • 1. Nanotechnology controlled drug delivery for treating bone diseases.
    Yang L; Webster TJ
    Expert Opin Drug Deliv; 2009 Aug; 6(8):851-64. PubMed ID: 19637973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarriers.
    Torchilin VP
    Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Designing drug-delivery systems for the nervous system using nanotechnology: opportunities and challenges.
    Liu-Snyder P; Webster TJ
    Expert Rev Med Devices; 2006 Nov; 3(6):683-7. PubMed ID: 17280531
    [No Abstract]   [Full Text] [Related]  

  • 4. Solid lipid nanoparticles for parenteral drug delivery.
    Wissing SA; Kayser O; Müller RH
    Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nanotechnology applications in pharmacology].
    Seĭfulla RD; Timofeev AB; Ordzhonikidze ZG; Rozhkova EA; Kulikova EV; Druzhinin AE; Kuznetsov IuM; Kim EK
    Eksp Klin Farmakol; 2008; 71(1):61-9. PubMed ID: 18365491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances and challenges of nanotechnology-based drug delivery systems.
    Jiang W; Kim BY; Rutka JT; Chan WC
    Expert Opin Drug Deliv; 2007 Nov; 4(6):621-33. PubMed ID: 17970665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid nanoparticles for parenteral delivery of actives.
    Joshi MD; Müller RH
    Eur J Pharm Biopharm; 2009 Feb; 71(2):161-72. PubMed ID: 18824097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery systems: entering the mainstream.
    Allen TM; Cullis PR
    Science; 2004 Mar; 303(5665):1818-22. PubMed ID: 15031496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part B: Delivery systems for BMPs in orthopaedic and craniofacial tissue engineering.
    Haidar ZS; Hamdy RC; Tabrizian M
    Biotechnol Lett; 2009 Dec; 31(12):1825-35. PubMed ID: 19690811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanotechnology approaches for drug and small molecule delivery across the blood brain barrier.
    Silva GA
    Surg Neurol; 2007 Feb; 67(2):113-6. PubMed ID: 17254859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanotechnology in the targeted drug delivery for bone diseases and bone regeneration.
    Gu W; Wu C; Chen J; Xiao Y
    Int J Nanomedicine; 2013; 8():2305-17. PubMed ID: 23836972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Past and future evolution in colloidal drug delivery systems.
    Boyd BJ
    Expert Opin Drug Deliv; 2008 Jan; 5(1):69-85. PubMed ID: 18095929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticles for direct nose-to-brain delivery of drugs.
    Mistry A; Stolnik S; Illum L
    Int J Pharm; 2009 Sep; 379(1):146-57. PubMed ID: 19555750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanotechnology and bone healing.
    Harvey EJ; Henderson JE; Vengallatore ST
    J Orthop Trauma; 2010 Mar; 24 Suppl 1():S25-30. PubMed ID: 20182231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticulate platforms for targeting bone infections: meeting a major therapeutic challenge.
    Santos-Ferreira I; Bettencourt A; Almeida AJ
    Nanomedicine (Lond); 2015; 10(20):3131-45. PubMed ID: 26446355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanosystem drug targeting: Facing up to complex realities.
    Ruenraroengsak P; Cook JM; Florence AT
    J Control Release; 2010 Feb; 141(3):265-76. PubMed ID: 19895862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of stimuli-responsive nanocarriers for drug and gene delivery.
    Ganta S; Devalapally H; Shahiwala A; Amiji M
    J Control Release; 2008 Mar; 126(3):187-204. PubMed ID: 18261822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
    Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
    J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.